Academic journals

Identification of Psychological Risk Factors in Orthopaedic Trauma Patients Could Improve Post-Injury Planning

Retrieved on: 
Monday, April 26, 2021
Medical specialties, Academic journals, Publications, Injury, Journal of Orthopaedic Trauma, The Journal of Bone and Joint Surgery, Trauma, Psychological trauma

A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) recognizes the intimate connection between patients who sustain traumatic orthopaedic injuries and their subsequent psychological effects.

Key Points: 
  • A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) recognizes the intimate connection between patients who sustain traumatic orthopaedic injuries and their subsequent psychological effects.
  • "We sought to demonstrate that of the vast number of people who will undergo orthopaedic trauma in their lifetime, an alarming percentage will develop some form of psychological condition that will ultimately impair daily function."\nDr.
  • Injury 2015;46:552-557.\n2McCarthy ML, MacKenzie EJ, Edwin D, Bosse MJ, Castillo RC, Starr A: Psychological distress associated with severe lower-limb injury.
  • J Bone Joint Surg Am 2003;85-A:1689-1697.\n3Busse JW, Heels-Ansdell D, Makosso-Kallyth, et al: Patient coping and expectations predict recovery after major orthopaedic trauma.

Okanagan College to Become the First Canadian Institution To Fully Adopt the FOLIO Library Services Platform

Retrieved on: 
Monday, April 26, 2021
EBSCO Information Services, EBSCO Industries, Okanagan College, Academic journals, Publishing, Mass media

b'IPSWICH, Mass., April 26, 2021 /PRNewswire-PRWeb/ -- Okanagan College (OC) will be the first institution in Canada to fully transition to the FOLIO Library Services Platform (LSP) using EBSCO FOLIO hosting and implementation services from EBSCO Information Services (EBSCO).

Key Points: 
  • b'IPSWICH, Mass., April 26, 2021 /PRNewswire-PRWeb/ -- Okanagan College (OC) will be the first institution in Canada to fully transition to the FOLIO Library Services Platform (LSP) using EBSCO FOLIO hosting and implementation services from EBSCO Information Services (EBSCO).
  • OC, located in British Colombia, is undertaking a phased implementation and will look to be entirely live on FOLIO before the end of 2021.\nEBSCO is one of the original founders of the FOLIO project and provides implementation, hosting and support through EBSCO FOLIO Services.
  • Okanagan College offers students bachelor\'s degrees, diplomas, trades and vocational training, professional development, corporate training and adult basic education.
  • EBSCO Information Services is a division of EBSCO Industries, Inc., a family-owned company since 1944.

Stryker to participate in the Bank of America Securities 2021 Virtual Health Care Conference

Retrieved on: 
Monday, April 26, 2021
Spine, Academic journals, Neurotechnology, Kalamazoo, Michigan, Investor relations, Publications

b"Kalamazoo, Michigan, April 26, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.\nSpencer Stiles, Group President, Orthopaedics & Spine, Robert Cohen, President, Digital, Robotics and Enabling Technologies and Preston Wells, Vice President, Investor Relations will represent the Company in a virtual presentation scheduled for 4:15 p.m. Eastern Time.\nA simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .

Key Points: 
  • b"Kalamazoo, Michigan, April 26, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.\nSpencer Stiles, Group President, Orthopaedics & Spine, Robert Cohen, President, Digital, Robotics and Enabling Technologies and Preston Wells, Vice President, Investor Relations will represent the Company in a virtual presentation scheduled for 4:15 p.m. Eastern Time.\nA simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at www.stryker.com .
  • The webcast will be archived on the Investor Relations page of this site.\nStryker is one of the world\xe2\x80\x99s leading medical technology companies and, together with its customers, is driven to make healthcare better.
  • The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
  • More information is available at www.stryker.com .\nFor investor inquiries please contact:\nFor media inquiries please contact:\n"

Amyris Hosts Successful Final Session Of Its Three-Part Virtual Mini-Series

Retrieved on: 
Monday, April 26, 2021
Academic journals, Amyris, Molecules, Trademark, Marketing, Publications

The presentation concluded with an overview of the Company\'s methodology for advancing molecules from discovery to commercialization, including its multi-factor development screening process.

Key Points: 
  • The presentation concluded with an overview of the Company\'s methodology for advancing molecules from discovery to commercialization, including its multi-factor development screening process.
  • Amyris uses an impressive array of exclusive technologies, including state-of-the-art machine learning, robotics and artificial intelligence.
  • Our ingredients are included in over 3,000 products from the world\'s top brands, reaching more than 200 million consumers.
  • For more information, please visit http://www.amyris.com .\nAmyris, the Amyris logo, No Compromise, Biossance, Pipette, and Purecane are trademarks or registered trademarks of Amyris, Inc. in the U.S. and/or other countries.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/amyris-hosts-successful-final-se...\n'

Meet the academics and research institutes taking part in the Trace Alliance Data Interoperability and Semantic Web Working Group

Retrieved on: 
Friday, April 23, 2021
Academic journals, Articles, Interoperability, Product testing, Telecommunications engineering, Publications, Semantic Web

An important part of the working group are the academics and research institutes, providing the normative backbone of the group's ambitions.\nThe first task of the working group is to complete a systematic literature review of peer-reviewed publications and document the current state of knowledge on data interoperability and Semantic Web in supply ecosystems.

Key Points: 
  • An important part of the working group are the academics and research institutes, providing the normative backbone of the group's ambitions.\nThe first task of the working group is to complete a systematic literature review of peer-reviewed publications and document the current state of knowledge on data interoperability and Semantic Web in supply ecosystems.
  • The output will be one or more working papers identifying the knowledge gaps that will form a foundation for the upcoming interoperability frameworks and pilot studies.
  • Members of the working group will be able to participate in webinars, joint project bids, best practices, and use-case documentation.
  • Members can also participate in the co-creation of working papers, white papers and contribute to peer-reviewed academic research publications that document data interoperability and Semantic Web research, use cases, and projects.\nThe joint working group is open for new members.

Meet the academics and research institutes taking part in the Trace Alliance Data Interoperability and Semantic Web Working Group

Retrieved on: 
Friday, April 23, 2021
Academic journals, Articles, Interoperability, Product testing, Telecommunications engineering, Publications, Semantic Web

An important part of the working group are the academics and research institutes, providing the normative backbone of the group's ambitions.\nThe first task of the working group is to complete a systematic literature review of peer-reviewed publications and document the current state of knowledge on data interoperability and Semantic Web in supply ecosystems.

Key Points: 
  • An important part of the working group are the academics and research institutes, providing the normative backbone of the group's ambitions.\nThe first task of the working group is to complete a systematic literature review of peer-reviewed publications and document the current state of knowledge on data interoperability and Semantic Web in supply ecosystems.
  • The output will be one or more working papers identifying the knowledge gaps that will form a foundation for the upcoming interoperability frameworks and pilot studies.
  • Members of the working group will be able to participate in webinars, joint project bids, best practices, and use-case documentation.
  • Members can also participate in the co-creation of working papers, white papers and contribute to peer-reviewed academic research publications that document data interoperability and Semantic Web research, use cases, and projects.\nThe joint working group is open for new members.

Boehringer Ingelheim and MD Anderson Expand Collaboration to Accelerate Development of KRAS and TRAILR2 Compounds in Lung Cancer

Retrieved on: 
Wednesday, April 14, 2021
Research, Clinical trials, Biotechnology, Health, University, Pharmaceutical, Science, Education, Oncology, Academic journals, Boehringer Ingelheim, KRAS, MD Anderson Cancer Center, Boehringer, Cancers, Publications, Economy of Germany

Under the new agreement, joint research will continue for five additional years.\n\xe2\x80\x9cOur collaboration with MD Anderson strengthens our determination to find solutions for the most difficult-to-treat cancers, and this latest commitment marks an important step forward, especially in our holistic KRAS program,\xe2\x80\x9d said Norbert Kraut, Ph.D., Head of Global Cancer Research at Boehringer Ingelheim.

Key Points: 
  • Under the new agreement, joint research will continue for five additional years.\n\xe2\x80\x9cOur collaboration with MD Anderson strengthens our determination to find solutions for the most difficult-to-treat cancers, and this latest commitment marks an important step forward, especially in our holistic KRAS program,\xe2\x80\x9d said Norbert Kraut, Ph.D., Head of Global Cancer Research at Boehringer Ingelheim.
  • \xe2\x80\x9cWe are delighted to extend our collaboration with MD Anderson.
  • Boehringer Ingelheim is pursuing a comprehensive mutant KRAS-directed effort with multiple programs expected to enter the VRDC with MD Anderson.\n\xe2\x80\x9cWe are proud to expand our work with Boehringer Ingelheim in a very exciting drug-development space \xe2\x80\x93 advancing novel targeted therapies against KRAS and TRAILR2,\xe2\x80\x9d said Timothy Heffernan, Ph.D., Head of Oncology Research in Therapeutics Discovery at MD Anderson.
  • No approved treatments for KRAS-driven cancers exist currently, further underscoring the need for continued investment in research and development.

Aries Announces Work Week Barrier Face Covering to Protect Today’s Workforce

Retrieved on: 
Tuesday, April 13, 2021
Medical Supplies, General Health, Health, Specialty, Engineering, Chemicals, Plastics, Manufacturing, Retail, Academic journals, Breathability, Textiles, Aries, Albums, Publications

b'Aries, maker of barrier face coverings, today announced the public release of the Aries Work Week Barrier Face Covering, which meets the newly released ASTM standard F3502-21 at Level 2 (high performance) for both filtration and breathability.

Key Points: 
  • b'Aries, maker of barrier face coverings, today announced the public release of the Aries Work Week Barrier Face Covering, which meets the newly released ASTM standard F3502-21 at Level 2 (high performance) for both filtration and breathability.
  • The Aries Work Week Barrier Face Covering provides business operators with a third-party tested and verified barrier face covering to protect their workforce for an entire 40-hour work week.\n"Companies want to return to work.
  • Employees want to be able to breathe freely and be comfortable through an 8-hour workday,\xe2\x80\x9d said Chris Evans, CEO of Aries USA.
  • The Aries Work Week Barrier Face Covering is one of the first to comply with the ASTM 3502 standard, delivering both filtration and breathability at Level 2, which are high performance standards.

The American College of Medical Genetics and Genomics Elects New Board Members, President-Elect

Retrieved on: 
Monday, April 12, 2021
Gynaecology, Obstetrics, Medical specialties, Academic journals, Health, ACMG, Obstetrics & Gynecology, Medical genetics, Genetics in Medicine, Obstetrics and gynaecology, American College of Medical Genetics and Genomics, Society of Family Planning

Dr. Klugman, a professor of obstetrics & gynecology and women\'s health, is board certified in clinical genetics by the American Board of Medical Genetics and Genomics (ABMGG) and in obstetrics and gynecology by the American Board of Obstetrics and Gynecology (ABOG).\nDr.

Key Points: 
  • Dr. Klugman, a professor of obstetrics & gynecology and women\'s health, is board certified in clinical genetics by the American Board of Medical Genetics and Genomics (ABMGG) and in obstetrics and gynecology by the American Board of Obstetrics and Gynecology (ABOG).\nDr.
  • Dr. Klugman is ACMG\'s representative to the American Medical Association\'s House of Delegates, liaison to the American College of Obstetricians and Gynecologists Committee on Genetics, and reproductive genetics editor for Genetics in Medicine.\nDr.
  • She is board certified in clinical genetics by the American Board of Medical Genetics & Genomics (ABMGG) and internal medicine by the American Board of Internal Medicine (ABIM).\n"I am honored and humbled to be elected by the ACMG membership to the Board of Directors.
  • Dr. Stevenson is also actively involved in a combination of clinical medical genetics practice, medical genetics education, and research.

Worldwide Cardiac Monitoring & Cardiac Rhythm Management Industry to 2025 - Competitive Analysis & Impact of COVID-19

Retrieved on: 
Friday, April 16, 2021
Cardiac electrophysiology, Heart Rhythm, Cardiac monitoring, Cardiovascular disease, Branches of biology, Publications, Academic journals

b'The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 21.6 Bn in 2020 and is expected to reach USD 27.31 Bn by 2025, growing at a CAGR of 4.8%.\nThe increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market.

Key Points: 
  • b'The Global Cardiac Monitoring & Cardiac Rhythm Management Market is estimated to be USD 21.6 Bn in 2020 and is expected to reach USD 27.31 Bn by 2025, growing at a CAGR of 4.8%.\nThe increasing instance of cardiovascular disorders is one of the foremost factors driving the cardiac rhythm management devices market.
  • This factor is one of the major factors that limits the scope of using cardiac rhythm management devices, as the implants are highly sensitive and their malfunctioning may have serious consequences.
  • In October 2020, Healthcare major Abbott confirmed its launch of next-generation heart rhythm management devices in India.
  • The impact of Covid-19 on the market is also featured in the report.\nThe report also contains the competitive analysis using IGR Competitive Quadrant, the analyst\'s proprietary competitive positioning tool.\nA complete analysis of the market, including parent industry\n'